Skip to the answer

Rocuronium Uses, Dosage, Side Effects and Interactions

Rocuronium is a muscle relaxant given by IV during general anesthesia to help place a breathing tube and keep muscles relaxed during surgery or mechanical ventilation.

Dr. Brian Staiger, PharmD, BCPS
Last reviewed Jul 10, 2026 Content updated Nov 12, 2026 Where our facts come from

Quick links

Ask Anything About RocuroniumType a question in your own words. Answered from its FDA label in seconds.

Every other section of this page is in the dots on the left edge of your screen: point at one to see where it goes.Every other section of this page is one tap away: use the arrow tab on the left edge of your screen.

Rocuronium in Short

The Pharmacist’s Take

Dr. Brian Staiger, PharmD, BCPS
Clinical pharmacist Written

Rocuronium is a muscle relaxant that anesthesia teams give by IV to help place a breathing tube and relax muscles during surgery or mechanical ventilation, working by blocking the nerve signal at the muscle; it has been a standard choice since about 1994, and FDA-approved generics are listed. Because it is given while you are asleep, most people notice little from it, though nausea, itching or a brief change in blood pressure or heart rate can occur. It stops the breathing muscles but does nothing for pain or awareness, so it is always paired with anesthesia and breathing support, and the risk to flag is a severe allergic reaction.

Key Takeaways From the HelloPharmacist Team

  • Expect it by IV only while you are under anesthesia, with a nerve stimulator tracking your muscles to guide any extra doses.
  • Tell your anesthesia team about any past reaction to a muscle relaxant, since allergies can cross over between these drugs.
  • Tell a nurse right away about muscle weakness or trouble breathing after surgery, since leftover paralysis can linger, especially in older adults.
  • List every medicine you take, since lithium, magnesium, some antibiotics and seizure drugs like phenytoin or carbamazepine change how long it works.

How we write and review this content: our editorial policy

Rocuronium by the Numbers

Strengths
2
in one form
Makers and packagers
25
Earliest FDA record
1994
Rank by Medicaid prescriptions
#694 of 1,682 drugs
More prescriptions than 58% of the 1,682 drugs we measure
38,861 prescriptions, Q1–Q4 2025

Patient Information Guide for Rocuronium

What It’s Used For

Rocuronium is used as part of general anesthesia care. The supplied injection labels (Rocuronium and Rocuronium Bromide, intravenous) list these uses:

  • Helping with routine tracheal intubation
  • Helping with rapid sequence tracheal intubation
  • Relaxing skeletal muscles during surgery
  • Relaxing skeletal muscles during mechanical ventilation

How It Works

Rocuronium is a nondepolarizing neuromuscular blocking agent. It competes for cholinergic receptors at the motor end-plate, where nerves signal muscles to contract. With the signal blocked, the muscles relax.

Its onset is rapid to intermediate depending on dose, and its duration is intermediate. Its action can be reversed by acetylcholinesterase inhibitors such as neostigmine and edrophonium.

Drug Class

Drug Class

  • Nondepolarizing Neuromuscular Blocker
Detailed classifications and sources

The FDA sorts a drug’s active ingredient by how it works, what it does in the body and its chemical structure, and gives it one main drug class.

Drug Class

Established Pharmacologic Class (EPC)
  • Nondepolarizing Neuromuscular Blocker

The main drug class the FDA gives it. It is the class named on the drug’s label.

How It Works

Mechanism of action (MoA)

None listed for Rocuronium in the FDA’s index.

What it does at the smallest level, such as a receptor or enzyme it blocks or switches on.

What It Does in the Body

Physiologic effect (PE)
  • Neuromuscular Nondepolarizing Blockade

A change it makes in how the body works.

Chemical Family

Chemical structure (CS)

None listed for Rocuronium in the FDA’s index.

The chemical family it belongs to, by its structure.

Drug Family

WHO ATC classification
  • Other quaternary ammonium compounds

How the World Health Organization groups it: by the part of the body it acts on and what it treats.

The classes are the FDA’s own words, from its index of drug labels, published in the National Library of Medicine’s RxClass. Read the FDA’s definitions. The drug family is the World Health Organization’s ATC classification. Reference only, not medical advice.

Dosage

Rocuronium is given only into a vein, by IV injection or continuous infusion, by experienced clinicians. It is not taken by mouth, so food and missed doses do not apply.

  • The dose is individualized for each patient
  • A nerve stimulator is recommended to check response and recovery
  • Maintenance doses depend on the response to the prior dose and are not given until recovery is evident
  • Continuous infusion starts only after early signs of spontaneous recovery from the first dose

Typical Doses

Your prescriber chooses your dose, so take it exactly as prescribed.

Muscle relaxation to help with a breathing tube and during surgery or ventilator use

Adults · Initial dose Dose 0.6 mg/kg
Adults · Lower initial dose Dose 0.45 mg/kg
  • 0.45 mg/kg may be used
Adults having rapid sequence intubation Dose 0.6 to 1.2 mg/kg

Good to know

Not recommended for rapid sequence intubation in pediatric patients

Adults · Maintenance dose Dose 0.2 mg/kg
  • 0.1, 0.15, and 0.2 mg/kg given at 25% recovery of control T1
  • Guided by clinical duration of prior dose and not given until recovery of neuromuscular function is evident
Adults · Continuous infusion Initial rate of 10 to 12 mcg/kg/min, started only after early evidence of spontaneous recovery from an intubating dose; infusion rates in clinical trials ranged from 4 to 16 mcg/kg/min

Good to know

Reduce rate by 30% to 50% at 45 to 60 minutes after intubating dose with steady-state enflurane or isoflurane

Adults who are obese · Initial dose Usual dose 0.6 mg/kg
  • Initial dose 0.6 mg/kg based on actual body weight
Children · Initial dose Usual dose 0.45 mg/kg

Step by step

  1. 0.6 mg/kg
  2. A lower dose of 0.45 mg/kg may be used depending on anesthetic technique and age
Children · Maintenance dose Dose 0.15 mg/kg
  • Bolus doses of 0.15 mg/kg at reappearance of T3, or at reappearance of T2 at a rate of 7 to 10 mcg/kg/min

What a maintenance dose is: The regular ongoing dose taken to keep a steady, effective amount of medicine in the body over time.

Children 3 months old through adolescence · Maintenance dose Dose 0.075 to 0.125 mg/kg
  • 0.075 to 0.125 mg/kg upon return of T1 to 0.25%, giving 7 to 10 minutes of relaxation
  • Or continuous infusion at 12 mcg/kg/min started upon return of T1 to 10%

What a maintenance dose is: The regular ongoing dose taken to keep a steady, effective amount of medicine in the body over time.

See the Full Dosing Instructions on DailyMed →

Side Effects

In studies, side effects were uncommon. The most common were:

Common side effects

  • Temporary low blood pressure
  • Temporary high blood pressure
  • Fast heart rate
  • Nausea or vomiting
  • Rash or itching
  • Swelling at the injection site
  • Hiccups or wheezing

When to get medical help

  • Severe allergic reaction (anaphylaxis), which can be life-threatening: tell your care team right away about swelling, trouble breathing, or a sudden rash
  • Muscle weakness or trouble breathing after surgery, which may signal leftover paralysis (residual paralysis)
  • Prolonged paralysis or muscle weakness after long-term use in the intensive care unit
  • Signs of malignant hyperthermia (a rare, dangerous reaction to anesthesia), which has been reported
  • Irritation, pain or swelling at the IV site if the drug leaks outside the vein

Severe allergic reactions, leftover paralysis, long-term muscle weakness after ICU use, and malignant hyperthermia have been reported and need immediate attention from the care team.

Warnings and Precautions

  • Paralysis risk: It paralyzes breathing muscles, so it is used only where ventilation, oxygen, intubation equipment and a reversal agent are immediately available.
  • Medication errors: Accidental use can cause respiratory arrest and death.
  • Anesthesia needed: It does not affect consciousness or pain, so sedation or anesthesia is required.
  • Anaphylaxis: Severe, sometimes fatal allergic reactions have been reported.
  • Residual paralysis: Recovery is confirmed before extubation. Adults 65 and older may be at higher risk.
  • Long ICU use: Tolerance and muscle weakness (myopathy) can occur, especially with corticosteroids.
  • Other cautions: QT interval prolongation in children with anesthetics, higher pulmonary vascular resistance, and IV site irritation if the drug leaks out of the vein.

Interactions

Several medicines can change how strong or long-lasting rocuronium is:

  • Certain antibiotics (aminoglycosides, vancomycin, tetracyclines, bacitracin, polymyxins, colistin): can prolong the block
  • Inhaled anesthetics such as enflurane and isoflurane: lengthen its effect and lower infusion needs
  • Magnesium, lithium, local anesthetics, procainamide: can enhance the block
  • Quinidine: linked to recurrent paralysis during recovery
  • Carbamazepine or phenytoin (long-term): can shorten the block and raise infusion needs
  • Succinylcholine: rocuronium should not be given until recovery from it is seen
  • Other nondepolarizing muscle relaxants: interactions have been observed
  • Alkaline solutions such as barbiturates: should not be mixed in the same syringe or IV line

Interactions Listed in the FDA-Approved Label

From the Rocuronium prescribing information (“Drug Interactions”): what the manufacturer studied or reported to the FDA.

  • Succinylcholine
    What happensUse of rocuronium before succinylcholine has not been studied; after succinylcholine, median duration of action of 0.6 mg/kg was 36 minutes vs 28 minutes without it.
    What to doDo not give rocuronium until recovery from succinylcholine has been observed.
  • Other nondepolarizing muscle relaxants
    What happensInteractions have been observed when given in succession; no controlled studies exist.
  • Inhalation anesthetics (enflurane, isoflurane, halothane)
    What happensEnflurane and isoflurane enhance activity, prolong duration of action and decrease infusion requirement by about 40%; no definite interaction with halothane.
    What to doReduce infusion rate by 30% to 50% under steady-state enflurane or isoflurane.
  • Antibiotics (aminoglycosides, vancomycin, tetracyclines, bacitracin, polymyxins, colistin, sodium colistimethate)
    What happensMay enhance neuromuscular blockade and prolong block.
  • What happensInjection during recovery from muscle relaxants is associated with recurrent paralysis.
  • Magnesium salts
    What happensGiven for pre-eclampsia or eclampsia, may enhance neuromuscular blockade.
  • What happensIncreases duration of neuromuscular block and decreases infusion requirements.
  • Local anesthetics
    What happensIncrease duration of neuromuscular block and decrease infusion requirements.
  • What happensIncreases duration of neuromuscular block and decreases infusion requirements.
  • Anticonvulsants (carbamazepine, phenytoin)
    What happensWith chronic use, shorter durations of neuromuscular block and higher infusion rates may occur due to resistance.
Read the label’s full interactions text

7 DRUG INTERACTIONS Succinylcholine: Use before succinylcholine has not been studied. Nondepolarizing muscle relaxants: Interactions have been observed. Enhanced Rocuronium Bromide Injection activity possible: Inhalation anesthetics, certain antibiotics, quinidine, magnesium, lithium, local anesthetics, procainamide Reduced Rocuronium Bromide Injection activity possible: Anticonvulsants. 7.1 Antibiotics Drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as Rocuronium Bromide Injection include certain antibiotics (e.g., aminoglycosides; vancomycin; tetracyclines; bacitracin; polymyxins; colistin; and sodium colistimethate). If these antibiotics are used in conjunction with Rocuronium Bromide Injection, prolongation of neuromuscular block may occur. 7.2 Anticonvulsants In 2 of 4 patients who received chronic anticonvulsant therapy, apparent resistance to the effects of another rocuronium bromide injection product was observed in the form of diminished magnitude of neuromuscular block or shortened clinical duration. As with other nondepolarizing neuromuscular blocking drugs, if Rocuronium Bromide Injection is administered to patients chronically receiving anticonvulsant agents such as carbamazepine or phenytoin, shorter durations of neuromuscular block may occur and infusion rates may be higher due to the development of resistance to nondepolarizing muscle relaxants. While the mechanism for development of this resistance is not known, receptor up-regulation may be a contributing factor. 7.3 Inhalation Anesthetics Use of inhalation anesthetics (enflurane > isoflurane > halothane) has been shown to enhance the activity of other neuromuscular blocking agents.

Excerpted: the section continues on the label. Read the full Drug Interactions section on DailyMed →

Not a complete list. The label covers the interactions the manufacturer studied or reported, and our own interaction database does not cover every medicine either. Bring your full medication list, including vitamins and herbal products, to your pharmacist.

Before You Start

  • Do not use with a known serious allergy (such as anaphylaxis) to rocuronium or other neuromuscular blocking agents
  • Myasthenia gravis or Eaton-Lambert syndrome: small doses can have strong effects
  • Liver impairment: use with caution, as the effect may last longer
  • Kidney impairment: usual dosing recommendations apply
  • Pregnancy: not recommended for rapid sequence induction in Cesarean section; no major birth defect risk was identified in available data, and the drug crosses the placenta
  • Breastfeeding: no data on milk transfer, so benefits and risks are weighed
  • Children: not recommended for rapid sequence intubation; onset and duration vary with age and anesthetic
  • Older adults: onset and duration may be slightly longer
  • Debilitated patients, those with neuromuscular disease, cancer-related wasting, or severe acid-base or electrolyte problems may respond more strongly or less predictably

Overdose

Too much rocuronium can cause muscle paralysis lasting longer than needed for surgery. Treatment is keeping the airway open, controlling breathing with a ventilator, and giving adequate sedation until normal muscle function returns. Once some spontaneous recovery is seen, a reversal medicine may be used.

Half-Life and How Your Body Processes It

After IV dosing, rocuronium spreads quickly through the body, with early distribution half-lives of about 1 to 2 minutes and 14 to 18 minutes. About 30% is bound to plasma proteins. The elimination half-life in adults is around 1.4 to 1.5 hours.

It is cleared mainly by the liver. In liver cirrhosis the half-life is about twice as long and the effect can last up to about 1.5 times longer. Kidney failure had little effect on average duration, though results varied more.

Storage

Stored at 20°C to 25°C (68°F to 77°F); Excursion permitted between 15°C and 30°C (59°F and 86°F) . DO NOT FREEZE.

Written from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI

Rocuronium: Pharmacist Answers to Common Questions

Quick, plain-English answers to the questions patients ask most about Rocuronium — the kind of thing our pharmacy team would talk through with you at the counter.

What is rocuronium used for?

It is a muscle relaxant used with general anesthesia. It helps the team place a breathing tube and keeps your muscles relaxed during surgery or while you are on a ventilator. You will be under anesthesia or sedation when you receive it.

How is rocuronium given?

It is given only through an IV by experienced clinicians. They tailor the dose to you and use a nerve stimulator to watch how your muscles respond. You do not need to take it yourself.

How long does rocuronium take to work and how long does it last?

In studies, most adults reached maximum muscle relaxation within a few minutes, often sooner with higher doses. Duration depends on the dose, your age and the anesthetic used. Adults 65 and older and people with liver disease may have a longer effect.

What side effects should I expect from rocuronium?

Side effects were uncommon in studies. The most common were temporary changes in blood pressure and a faster heart rate. Some people had nausea, rash, itching or hiccups. Your team monitors you closely throughout.

Can I take rocuronium if I have liver or kidney problems?

With liver disease, it is used with caution because the liver clears it and the effect can last longer. With kidney problems, usual dosing is followed, though how long it lasts can vary more. Tell your anesthesia team about any liver or kidney problems.

Is rocuronium safe if I'm pregnant?

Available data have not shown a major birth defect or pregnancy loss risk, but the drug does cross the placenta. It is not recommended for rapid sequence induction in Cesarean section. Tell your team if you are pregnant or in labor.

Is rocuronium available over the counter?

No. Rocuronium is a prescription medicine: every rocuronium product listed with the FDA is prescription only, so it is not sold over the counter. Your prescriber decides whether it is appropriate for you, and your pharmacist dispenses it.

When was rocuronium first available?

The earliest FDA record we hold for rocuronium is from 1994: its first approval in Drugs@FDA or its earliest product listing in the NDC Directory, whichever is older. Many older medicines were in use before their first formal FDA approval, so this is the earliest date on record, not necessarily when rocuronium was first used.

Who makes rocuronium?

25 companies currently list rocuronium products in the FDA's NDC Directory, including Medical Purchasing Solutions, LLC, Fresenius Kabi USA, LLC, HF Acquisition Co LLC, DBA HealthFirst. That count includes repackagers and distributors as well as manufacturers (companies that sell only the raw ingredient are not counted), so fewer companies actually make it; the label on your bottle names the one that supplied yours.

What drug class is rocuronium?

Rocuronium belongs to the drug class Nondepolarizing Neuromuscular Blocker, its established pharmacologic class on the FDA label.

Is there a generic version of rocuronium?

Yes. FDA-approved generic versions of rocuronium are listed in the FDA's National Drug Code Directory. A listing does not prove that every pharmacy stocks one, so your pharmacy can tell you which version it carries.

What strengths does rocuronium come in?

Rocuronium is listed in the FDA's National Drug Code Directory in these forms and strengths. Injection (into a vein): 50 mg/5 mL and 100 mg/10 mL. A listing does not mean every pharmacy stocks every strength.

How much does rocuronium cost?

What you pay depends on your insurance, your pharmacy and the strength you take. As a benchmark, pharmacies paid a national average of $0.39 per mL of the generic injection across 2 strengths as of May 13, 2026 (CMS's NADAC survey). That is the pharmacy's own cost for the medicine, not the price at the counter. The pharmacy prices section of this page lists every strength priced.

Is there a rocuronium shortage?

Yes. Rocuronium is on the FDA's drug shortage list as of Nov 22, 2026. A shortage means some products are hard to get, not that every pharmacy is out. The shortage page lists the affected products and what each company has told the FDA. Read the rocuronium shortage page

Where can I read the rocuronium prescribing information (package insert)?

The full FDA-approved prescribing information for rocuronium, also called the package insert or drug label, is published on DailyMed, the National Library of Medicine's library of FDA labels. Each company's version has its own label; this page is built from Fresenius Kabi USA, LLC's, revised Aug 2, 2026, and links to it on DailyMed.

Is rocuronium gluten free?

No rocuronium label we read lists an ingredient made from wheat, barley or rye, the grains that carry gluten, and none names a starch, dextrin or maltodextrin without saying where it comes from. We read the FDA labels of 66 rocuronium products from 25 companies. A label lists ingredients; it is not a gluten test, so we cannot promise that any product has no gluten. If you have celiac disease, ask the company for a written gluten statement. Our Inactive Ingredient Checker shows each company's rocuronium by strength and NDC, and whether its label lists a gluten source, lactose, dyes or any other inactive ingredient. See rocuronium inactive ingredients by company

Answers drafted from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI

Ask Anything About Rocuronium

Skip the scrolling. Ask in your own words and get an answer from Rocuronium’s FDA label and our pharmacists’ own work.

Try:

Name another drug or a supplement in your question and we check both.

AI answers from FDA labels and our own records, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.How this works
  • Sources: Rocuronium’s FDA label, including the clinical studies it reports, and the label of any drug you name; our pharmacists’ own work, such as our Do Not Crush list and our published answers to readers’ questions; our pharmacy prices and the Natural Medicines supplement database.
  • Written by AI: Answers are written by AI from those sources, and AI can make mistakes. Check what you read here with your doctor or pharmacist before you act on it.
  • Reviewed afterward: Our pharmacy team reviews every question and answer afterward to check it for accuracy, and when we find an error, we correct how the box answers. Read more in How we use AI.
  • Not medical advice. In an emergency, call 911, Poison Control at 1-800-222-1222, or 988.

More About Rocuronium on HelloPharmacist

Still have a question? A licensed pharmacist answers for free, as soon as they can.
Detailed Data & References for Rocuronium Forms and strengths, pricing, billing codes, manufacturers, safety reports and sourcing: the data behind the page. Most people can stop here. Each section below opens on a tap.

Rocuronium Forms and Strengths (How It Comes)

Rocuronium comes in 1 dose form, the injection. Different forms and brands can have different approved uses, doses, schedules, and directions. Follow the instructions for your exact product, and do not switch forms without guidance from your prescriber or pharmacist.

Need a version that does not list lactose, a gluten source, a dye or gelatin? Inactive ingredients differ by manufacturer: see Rocuronium inactive ingredients by manufacturer.

Injection

Into a vein
How this form is used
What it may be used for
  • Rocuronium Bromide injection is used with general anesthesia to help with routine and rapid sequence tracheal intubation
  • Rocuronium Bromide injection provides skeletal muscle relaxation during surgery or mechanical ventilation
Important instructions
  • Rocuronium Bromide injection is for intravenous use only
  • Rocuronium Bromide injection should be given only by experienced clinicians or trained people supervised by one
  • Rocuronium Bromide injection doses are individualized, and a nerve stimulator is recommended to monitor response
  • Rocuronium Bromide injection should be stored with the cap and ferrule intact to avoid wrong-product mix-ups
Available strengths 3 strengths
67 FDA-listed product records ⓘ

Rocuronium on the U.S. Market: Products, Makers and Brands

How Rocuronium appears in the FDA’s National Drug Code Directory — including its dosage forms, strengths, brand names, manufacturers, and FDA-listed product records. These are directory records, not sales or prescription volume.

25 companies list 67 Rocuronium product records with the FDA, mostly as injection; the earliest marketing or approval year on record is 1994.

1
Dose forms ⓘ
25
Labelers (makers, repackagers, distributors)
67
FDA-listed product records ⓘ
1994
Earliest FDA record ⓘ

Also listed with the FDA, not a patient dose form: Powder (12) — bulk drug substance and unfinished product sold to compounders and other manufacturers to finish, and multi-item kits. These aren’t counted in the dose-form total above.

Medical Purchasing Solutions, LLC13%
Fresenius Kabi USA, LLC12%
HF Acquisition Co LLC, DBA HealthFirst12%
Hospira, Inc.7%
Baxter Healthcare Corporation6%
ProPharma Distribution4%
Other makers45%

Share of FDA-listed product records by manufacturer — FDA National Drug Code Directory. Record counts are not sales or prescription volume.

How Widely Rocuronium Is Used (Medicaid Data)

How many Rocuronium prescriptions Medicaid paid for in Q1–Q4 2025, every brand, strength and form together. Medicaid is one program, so total U.S. use is higher.

38,861
Medicaid prescriptions filled (Q1–Q4 2025)
$3M paid by Medicaid, before rebates

How commonly is Rocuronium prescribed? Of the 1,682 medications we measure, Rocuronium ranks #694 by Medicaid prescriptions — more than 59% of them.

Where Rocuronium ranks among the drugs we measure · Q1–Q4 2025 · neighbors ±5

Utilization by Rocuronium product

Pick a strength and form to see its own numbers. Brand and generic versions are counted together.

rocuronium bromide 10 MG/ML Injectable Solution

38,861 Medicaid prescriptions (Q1–Q4 2025) 100% of Rocuronium prescriptions shown $3M paid by Medicaid, before rebates ≈ $77 per prescription, before rebates

34 of 131 listed NDCs had Medicaid claims. RxNorm 1234995

Dollars are what Medicaid paid before the rebates drug makers send back, so its real cost is lower.

Source: Medicaid State Drug Utilization Data (CMS), all states. 34 of the 131 listed Rocuronium NDCs had Medicaid claims.

Compare Rocuronium Products

A representative set of FDA-listed product records for Rocuronium — across manufacturers, strengths, and dosage forms, grouped by form with each product’s manufacturer and how the FDA approved it. The same medicine may be made and packaged by different companies, so a single drug can have many directory entries. (It’s also why a refill can look different — a new shape, color, or box — even though it contains the same medication.)

Showing 67 of 67 products — FDA National Drug Code Directory. See every product, package size and price: browse all 67 Rocuronium NDCs →

Rocuronium Side Effects Reported to the FDA (FAERS)

After a medicine reaches the market, patients, doctors and drugmakers can send the FDA reports of problems they think may be linked to it. Here’s what’s been reported for Rocuronium — a signal of what to watch for, not proof the drug caused it.

The effects most often named in FDA reports that mention Rocuronium are anaphylactic reaction, hypotension, anaphylactic shock; about 91% of the reports were classed as serious. These are voluntary reports, so they show what people report, not how often it happens.

12,125
Reports mentioning it
91%
Reported as serious
12
Distinct effects shown
Most reported effects
Anaphylactic Reaction
1,326
Hypotension
1,158
Anaphylactic Shock
1,073
Cardiac Arrest
685
Drug Interaction
476
Tachycardia
435
Bradycardia
404
Bronchospasm
385
Rash
297
Urticaria
287
Age groups
Adult · 1,153Elderly · 517Child · 321Neonate · 141Infant · 58Adolescent · 55

Source: openFDA, from the FDA Adverse Event Reporting System (FAERS). These are voluntary reports — they don’t prove the drug caused the effect, and counts reflect how often something was reported, not how often it actually happens. Reports also often name the very problem the medicine is taken for — a common reason to file one is that the drug didn’t help — so for a pain reliever you may see “pain” high on the list; that points to why the report was filed, not to the drug causing the symptom. This counts every report that lists Rocuronium in any role, so the total runs higher than the FDA’s official dashboard, which counts only cases where the drug is the suspect. For the authoritative figures, see the FDA FAERS Public Dashboard. Always talk to your pharmacist or doctor.

Rocuronium FDA Approval History

How Rocuronium went from FDA review to the pharmacy shelf — the key milestones in its regulatory journey.

Rocuronium was first approved by the FDA in 1994 (Brand: ZEMURON · Organon Usa Inc); the first generic version was approved in 2008. It remains available in U.S. pharmacies today.

1994
Brand approved
Brand: ZEMURON · Organon Usa Inc
2008
First generic approved
Lower-cost ANDA competition begins
2026
Available today
Active in U.S. pharmacies

Source: Drugs@FDA.

Rocuronium Recall History

A recall is when a specific batch of a medicine is pulled from the market — usually a manufacturing issue, not a problem with the drug itself. Class I is most serious, Class III least.

The FDA’s enforcement reports list one Rocuronium recall since July 2021. It is no longer listed as ongoing. A recall names specific lots from one company, so check the lot number on your own bottle rather than assuming every product is affected; your pharmacist can check whether your supply came from an affected lot.

Class II Feb 7, 2024 · Terminated · Mckesson Medical-Surgical Inc. Corporate Office
cGMP Deviations: Products were stored outside the drug label specifications.
  • Rocuronium Bromide Injection, Preservative Free, 10 mg / mL, Multiple-Dose Vial 10 mL, Rx only, Mfg: Auromedics Pharma LLC, NDC 55150-226-10 Lots: 1064081 FDA record D-0371-2024 →

Source: FDA enforcement (recall) reports, via openFDA; our copy was last updated Nov 19, 2026.

Rocuronium in RxNorm: From Ingredient to Every Form and Strength

RxNorm is the U.S. National Library of Medicine’s standard name for every version of a medicine, the code pharmacy and prescribing systems share. This page starts from one ingredient (IN); each dose form (SCDF) branches from it, and each exact strength (SCD) from its form. Combination products are separate concepts with their own pages.

Dose forms
3
Strengths
5
Forms in current FDA listings
3 of 3
In current FDA listings No current FDA listing
Ingredient (IN) Rocuronium RxCUI 68139
  1. Dose form (SCDF) Injectable Solution RxCUI 375623
    In current FDA listings
    Its strength (SCD)
  2. Dose form (SCDF) Injection RxCUI 2720022
    In current FDA listings
    Its 2 strengths (SCD)
  3. Dose form (SCDF) Prefilled Syringe RxCUI 2740931
    In current FDA listings
    Its 2 strengths (SCD)

RxNorm is the U.S. National Library of Medicine’s normalized drug vocabulary. Its concept hierarchy can include forms that are not currently marketed; the status on each branch compares that concept with current FDA listings. RxCUIs identify vocabulary concepts, not individual packages or manufacturers.

Rocuronium Supply and Shortage Status

Whether Rocuronium is in short supply in the U.S. right now, plus any shortage history the FDA has on record. A shortage usually reflects a manufacturing or demand issue — not a safety problem with the drug.

Rocuronium is currently listed in shortage by the FDA (10 presentations on record).

⚠️Currently in shortage (FDA) — Rocuronium

Read the full Rocuronium shortage page — affected NDCs, other makers, and what to do →

Current Rocuronium Bromide, Injection, 100 mg/10 mL (NDC 55150-226-10)
Eugia US LLC · Since 02/15/2023 · Updated 11/19/2026
Current Rocuronium Bromide, Injection, 50 mg/5 mL (NDC 55150-225-05)
Eugia US LLC · Since 02/15/2023 · Updated 11/19/2026
Current Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 67457-228-10)
Mylan Institutional, a Viatris Company · Since 02/15/2023 · Updated 11/18/2026
Current Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 65219-065-05)
Fresenius Kabi USA, LLC · Since 02/15/2023 · Updated 11/18/2026
Reason: Delay in shipping of the drug
Current Rocuronium Bromide, Injection, 100 mg/10 mL (NDC 43066-013-10)
Baxter Healthcare · Since 02/15/2023 · Updated 11/18/2026
Current Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 63323-426-10)
Fresenius Kabi USA, LLC · Since 02/15/2023 · Updated 11/18/2026
Current Rocuronium Bromide, Injection, 50 mg/5 mL (NDC 43066-007-10)
Baxter Healthcare · Since 02/15/2023 · Updated 11/18/2026
Current Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 67457-228-05)
Mylan Institutional, a Viatris Company · Since 02/15/2023 · Updated 11/18/2026
Current Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 65219-444-10)
Fresenius Kabi USA, LLC · Since 02/15/2023 · Updated 11/18/2026
Current Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 63323-426-05)
Fresenius Kabi USA, LLC · Since 02/15/2023 · Updated 11/18/2026
Reason: Delay in shipping of the drug

Source: openFDA, from the FDA Drug Shortages database.

What Rocuronium Costs Pharmacies (NADAC Benchmark)

What pharmacies pay to buy Rocuronium: the national average from CMS’s weekly NADAC survey, as of May 13, 2026. It is the pharmacy’s cost, not your price at the counter.

How the Pharmacy Price Has Changed

Pick a strength to see how its price has changed since Jun 2024.

Strength

For the generic 10 mg/mL injection, pharmacies paid an average of $0.394 per mL as of May 13, 2026, down 25% from $0.526 a year earlier.

What pharmacies pay now
$0.394
per mL, as of May 13, 2026
Last 4 weeks
No change
from $0.394 on Apr 15, 2026
Last 12 months
Down 25%
from $0.526 on May 14, 2025
Lowest and highest since Jun 2024
$0.394 to $0.538
per mL

Each step is one weekly survey. Arrow keys on the chart move week by week.
See the numbers, month by month
Generic 10 mg/mL injection: the average pharmacy price per mL, the last survey of each month
MonthPharmacy price
May 2026$0.394
Apr 2026$0.394
Mar 2026$0.394
Dec 2025$0.526
Nov 2025$0.526
Oct 2025$0.526
Sep 2025$0.526
Aug 2025$0.526
Jul 2025$0.526
Jun 2025$0.526
May 2025$0.526
Apr 2025$0.526
Mar 2025$0.526
Feb 2025$0.526
Jan 2025$0.526
Dec 2024$0.526
Nov 2024$0.526
Oct 2024$0.526
Sep 2024$0.538
Aug 2024$0.538
Jul 2024$0.538
Jun 2024$0.538
FormStrengthVersion What pharmacies pay
Injection · Intravenous 10 mg/mL Generic $0.394 per mL NDC details & price history
Injection · Intravenous 50 mg/5 mL Generic $0.394 per mL NDC details & price history
Why it helps: it shows whether the drug itself is cheap or costly, and whether a cash price you are quoted is in a reasonable range. What you pay also depends on your insurance and pharmacy.

Source: CMS National Average Drug Acquisition Cost (NADAC). Each row spans the package sizes CMS priced; the generic and the brand are priced separately.

Who Makes Rocuronium: Manufacturers and Labelers

25 companies list Rocuronium products with the FDA. By number of product records, the largest are Medical Purchasing Solutions, LLC, Fresenius Kabi USA, LLC, HF Acquisition Co LLC, DBA HealthFirst. Labelers include manufacturers and repackagers; the product in your bottle depends on which one your pharmacy stocks.

Medical Purchasing Solutions, LLC 9 Fresenius Kabi USA, LLC 8 HF Acquisition Co LLC, DBA HealthFirst 8 Hospira, Inc. 5 Baxter Healthcare Corporation 4 ProPharma Distribution 3 BE Pharmaceuticals Inc. 2 Caplin Steriles Limited 2 Civica, Inc. 2 Eugia US LLC 2 Gland Pharma Limited 2 Hikma Pharmaceuticals USA Inc. 2 Lifestar Pharma LLC 2 Meitheal Pharmaceuticals Inc. 2 Piramal Critical Care Inc 2 Shandong New Time Pharmaceutical Co., Ltd. 2 Solco Healthcare US, LLC 2 B. Braun Medical Inc. 1 Bryant Ranch Prepack 1 Mylan Institutional LLC 1 Phlow Corporation 1 Steriscience Specialties Private Limited 1 Sagent Pharmaceuticals 1 Sandoz Inc 1

…and 1 more on the FDA NDC directory.

Sources for This Rocuronium Page

Core label, product, RxNorm, safety, and utilization data on this page come from the sources identified below. AI-written, editorial, and licensed sections are labeled separately.

📄
FDA-filed drug labels (SPL) Uses, dosing, warnings & side effects from SPL records retrieved through openFDA; the linked representative set can be verified on DailyMed. Prescribing information dated Aug 2, 2026, the label version this page reads. A label changes when the FDA approves new uses, doses or warnings, so this is not the day the page itself last changed. Read the full label on DailyMed
🏭
Forms, brands & labelersAggregated from ingredient-matched FDA National Drug Code Directory product records for Rocuronium.
📈
Real-world reportsThe FDA Adverse Event Reporting System (FAERS), served through openFDA.
🚨
Recalls & shortagesopenFDA drug-enforcement reports and the FDA drug-shortage database.

Where this information comes from

The clinical label records used on this page are FDA-filed Structured Product Labeling (SPL) retrieved through openFDA. We identified 52 clinical label sets within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. Forms, routes, brands, labelers, strengths, and NDC product-record counts are built separately from matching FDA National Drug Code Directory records. The linked DailyMed document is a representative official source for verification, not the page’s only clinical source.

Clinical labels in scope
52
Finished products in the current FDA directory
67
Companies listing them (makers, repackagers, distributors)
25
FDA labeler codes behind them ⓘ
27
Linked representative label ⓘ
Fresenius Kabi USA, LLC
Linked label effective
Aug 2, 2026
Composite sections available
22
Linked SPL Set ID
04c9812d-5aa3-4949-ad02-c618028f1bb0
Linked SPL Document ID
fbd1fcf9-ffaa-46f6-81ca-18d3fbc1dcee
Open the linked representative label on DailyMed ↗

How this page is built

HelloPharmacist combines public FDA and NLM records and does not author the underlying clinical facts. The plain-language sections are written with AI from the FDA-approved label text and reviewed by our pharmacy team before publication. Fresenius Kabi USA, LLC is the representative DailyMed label linked for verification and dates. This is general education, not medical advice: always talk to your doctor or pharmacist about your own medicines. How we build and review drug pages →